Sponsored by:

Molecular Imaging: Page 449

ACR advises on Tc-99m shortage
By AuntMinnie.com staff writers
The Reston, VA-based American College of Radiology (ACR) says "severe cutbacks" are occurring in nuclear cardiology with the loss of more than 50% of the North American molybdenum-99 (Mo-99) supply, due to the prolonged shutdown of the Chalk River nuclear reactor in Ottawa, Canada.
December 10, 2007
AMIC speeds up launch date for technetium generators
By AuntMinnie.com staff writers
Medical isotope developer Advanced Medical Isotope (AMIC) said that it is accelerating the launch of its compact generator systems and technology in response to the extended shutdown of a Canadian reactor producing the base isotope for technetium-99m.
December 10, 2007
Gamma Medica notches sale to Louisiana health center
By AuntMinnie.com staff writers
Gamma camera developer Gamma Medica-Ideas of Northridge, CA, has sold one of its Flex Triumph multimodality preclinical molecular imaging systems to Louisiana State University Health Sciences Center in Shreveport.
December 6, 2007
UM researchers develop 'green' nanoparticles for cancer treatment
By Wayne Forrest
Nanotechnology is going green with the help of some magic beans -- OK, actually they're soybeans. A group of researchers at the University of Missouri-Columbia (UM) has developed a method of using natural ingredients like soybeans to produce gold nanoparticles for the diagnosis and treatment of cancerous tumors.
December 6, 2007
2007 12 06 17 04 00 706
Warning issued on radioisotope supply
By Wayne Forrest
Radioisotope maker Atomic Energy of Canada Ltd.'s (AECL) National Research Universal reactor in Chalk River, Ontario, will be offline for at least one more month, leaving hundreds of thousands of medical tests worldwide in jeopardy.
December 5, 2007
Radioisotope shortage looms; improving imaging quality
By Brian Casey
December 5, 2007
ART scores two Optix orders
By AuntMinnie.com staff writers
Medical device firm ART Advanced Research Technologies of Montreal received two orders for its Optix MX2 preclinical optical molecular imager, the company said.
December 5, 2007
Bristol-Myers Squibb to divest imaging unit, including Cardiolite radiopharmaceutical
By Brian Casey
Pharmaceutical giant Bristol-Myers Squibb is planning to sell off its medical imaging unit as part of a restructuring of the New York City-based company. The firm's medical imaging division markets the Cardiolite technetium-based radiopharmaceutical, as well as other radiopharmaceuticals and ultrasound contrast media.
December 4, 2007
MDS Nordion divests two product lines
By AuntMinnie.com staff writers
Radioisotope developer MDS Nordion of Kanata, Ontario, announced the sale of its external beam therapy and self-contained irradiator product lines in a move to focus the firm's resources on molecular medicine initiatives.
November 29, 2007
PET does not predict survival in advanced lung cancer
By Eric Barnes
CHICAGO - Studies over the past several years have demonstrated FDG-PET's ability to predict survival in patients with early-stage lung cancer. But for those with advanced non-small cell lung cancer (NSCLC), PET has no prognostic value, according to a new 15-year study from Duke University Medical Center in Durham, NC.
November 28, 2007
Triple-negative breast cancers show marked clinical features
By Kate Madden Yee
CHICAGO - Women diagnosed with triple negative (TN) breast cancer -- in which the tumor is estrogen receptor-negative, progesterone receptor-negative, and HER2-negative -- tend to have fewer treatment options and worse prognoses than women with non-TN tumors. But certain characteristics and imaging features may help clinicians diagnose these tumors earlier, according to a presentation at the RSNA 2007 meeting.
November 28, 2007
Neoprobe, Cardinal Health ink distribution deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has signed a distribution agreeement with healthcare products firm Cardinal Health, also of Dublin, for the marketing and distribution of its Lymphoseek radiopharmaceutical through Cardinal's network of more than 150 nuclear pharmacies.
November 27, 2007
Previous Page
Page 449 of 615
Next Page